Your browser doesn't support javascript.
loading
Benefits and risks of extended treatment of venous thromboembolism with rivaroxaban or with aspirin.
Prandoni, Paolo; Lensing, Anthonie W A; Prins, Martin H; Gebel, Martin; Pap, Akos F; Homering, Martin; Bauersachs, Rupert; Beyer-Westendorf, Jan; Bounameaux, Henri; Cohen, Alexander T; Davidson, Bruce L; van Bellen, Bonno; Verhamme, Peter; Wells, Philip S; Yuan, Zhong; Levitan, Bennett; Weitz, Jeffrey I.
Afiliação
  • Prandoni P; Department of Cardiothoracic & Vascular Sciences, Vascular Medicine Unit, University of Padua, Italy.
  • Lensing AWA; Bayer AG, Leverkusen, Germany.
  • Prins MH; Department of Epidemiology and Technology Assessment, University of Maastricht, Maastricht, The Netherlands.
  • Gebel M; Bayer AG, Leverkusen, Germany.
  • Pap AF; Bayer AG, Leverkusen, Germany.
  • Homering M; Bayer AG, Leverkusen, Germany.
  • Bauersachs R; Department of Vascular Medicine, Klinikum Darmstadt GmbH, Germany.
  • Beyer-Westendorf J; Department of Hematology, Medical Clinic I, University Hospital "Carl Gustav Carus" Dresden, Germany; Department of Haematology, Oncology Kings College London, UK.
  • Bounameaux H; Division of Angiology and Hemostasis, University Hospitals of Geneva, Faculty of Medicine, Geneva, Switzerland.
  • Cohen AT; Department of Haematological Medicine, Guys and St Thomas' Hospitals, King's College Hospital, London, UK.
  • Davidson BL; University of Washington School of Medicine, Seattle, WA, USA.
  • van Bellen B; Hospital Beneficência Portuguesa, São Paulo, Brazil.
  • Verhamme P; Vascular Medicine and Hemostasis, University of Leuven, Belgium.
  • Wells PS; Department of Medicine, University of Ottawa, Ottawa Hospital Research Institute, Ontario, Canada.
  • Yuan Z; Janssen Research & Development, Raritan, NJ, USA.
  • Levitan B; Janssen Research & Development, Raritan, NJ, USA.
  • Weitz JI; Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton, Ontario, Canada. Electronic address: weitzj@taari.ca.
Thromb Res ; 168: 121-129, 2018 08.
Article em En | MEDLINE | ID: mdl-30064683
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Métodos Terapêuticos e Terapias MTCI: Terapias_biologicas / Aromoterapia Assunto principal: Inibidores da Agregação Plaquetária / Aspirina / Tromboembolia Venosa / Inibidores do Fator Xa / Rivaroxabana Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Revista: Thromb Res Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Itália
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Métodos Terapêuticos e Terapias MTCI: Terapias_biologicas / Aromoterapia Assunto principal: Inibidores da Agregação Plaquetária / Aspirina / Tromboembolia Venosa / Inibidores do Fator Xa / Rivaroxabana Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Revista: Thromb Res Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Itália